subject: Bronchitis - Drug Pipeline Analysis And Market Forecasts [print this page] Bronchitis - Drug Pipeline Analysis and Market Forecasts
GlobalData's pharmaceutical and healthcare report offering, Bronchitis Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global bronchitis market. The report identifies the key trends shaping and driving the global bronchitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global bronchitis sector. ( http://www.bharatbook.com/detail.asp?id=136397&rt=Bronchitis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html )
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.
The global bronchitis market was valued at $482m in 2009 and is forecast to grow by 3.7% annually for the next seven years. The typical form of bronchitis is self-limited. The bronchitis market is characterized by many generics and OTC. The NSAIDS, cough suppressants and antipyretics are mere supportive therapies. Antibiotics are highly prescribed to treat atypical form of the disease. The increase in the market size is attributed to the increase in incidence and increase in the up take of cost effective drugs
There are 13 molecules in the various phases of the developmental pipeline. Of these, only five are in Phase III and the rest are in the early stages of development. The pipeline consists of no new antibiotics. The antibiotics in the pipeline are generic. Upon approval they will add to the competition. The phase of the pipeline consists of levefloxacin and Mercks Singulair. Upon approval they are expected to intensify the competition
Scope
The scope of the report includes:
- Annualized global bronchitis market revenues data from 2001 to 2009, forecast for seven years to 2016.
- Geographies covered in this report are the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include alpha 1 adrenergic receptors agonist, beta (2)-adrenergic agonist,, anti-inflammatory, inhibitor topoisomerase IV DNA gyrase, glucocorticoid agonist leukotriene D4 antagonist and loop diuretic
- Analysis of the current and future market competition in the global bronchitis market. The key market players covered are Merck and Co and Johnson & Johnson Pharmaceutical Research & Development, Pfizer and Merck & Co.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future bronchitis market.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global bronchitis market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global bronchitis market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Whats the next big thing in the global bronchitis market landscape? Identify, understand and capitalize.
To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=136397&rt=Bronchitis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html
Related Reports :
Huntingtons Disease - Drug Pipeline Analysis and Market Forecasts
